<?xml version="1.0" encoding="UTF-8"?>
<p>In patients with chronic inflammatory arthropathy, the use of bDMARDs does not seem to be associated with worse outcomes in patients infected by CHIKV, and we observed a lower frequency of chronic joint symptoms that may be related to possible TNF blockade in the presence of CHIKV infection.</p>
